(Q35826370)

10 August 2017

1 reference

title

Targeting plasmid-encoded proteins to the antigen presentation pathways (English)

1 reference

10 August 2017

Jens A Leifert

1

1 reference

10 August 2017

Maria P Rodriguez-Carreno

series ordinal

2

1 reference

10 August 2017

Fernando Rodriguez

series ordinal

3

1 reference

10 August 2017

J Lindsay Whitton

series ordinal

4

1 reference

10 August 2017

1 June 2004

1 reference

10 August 2017

Immunological Reviews

1 reference

10 August 2017

199

1 reference

10 August 2017

40-53

1 reference

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Enhancing DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Antigen presentation and DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

A new foreign policy: MHC class I molecules monitor the outside world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Capture and processing of exogenous antigens for presentation on MHC molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

The cell biology of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

The cell biology of MHC class I antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Antigen presentation to CD8+ T cells: cross-priming in infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

The cell biology of antigen presentation in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

On cross-priming of MHC class I-specific CTL: rule or exception?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Recycling MHC class I molecules and endosomal peptide loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Intracellular localization of proteasomal degradation of a viral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

The N-end rule: functions, mysteries, uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Protection against mycoplasma infection using expression-library immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

An autologous oral DNA vaccine protects against murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Estimating the precursor frequency of naive antigen-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Early programming of T cell populations responding to bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Direct observation of ligand recognition by T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Heat shock protein 70-associated peptides elicit specific cancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Messenger proteins: homeoproteins, TAT and others

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Protein transduction: an alternative to genetic intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

A genetic immunization adjuvant system based on BVP22-antigen fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

"Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Intercellular trafficking of VP22-GFP fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Evaluation of VP22 spread in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Intercellular spread of GFP-VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Is VP22 nuclear homing an artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Heparin binding by the HIV-1 tat protein transduction domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cell surface adherence and endocytosis of protein transduction domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Mhc-guided processing: binding of large antigen fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Potential sites for processing of the human invariant chain by cathepsins D and E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Isolation of a membrane-associated cathepsin D-like enzyme from the model antigen presenting cell, A20, and its ability to generate antigenic fragments from a protein antigen in a cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Induction of antigen specific CD4+ T cell responses by invariant chain based DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Type I interferon is required to mount an adaptive response to immunostimulatory DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Cross-presentation: a general mechanism for CTL immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Positively charged DNA-binding proteins cause apparent cell membrane translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.0135.X

Introduction of soluble protein into the class I pathway of antigen processing and presentation

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(88)91043-4

Identifiers

DOI

10.1111/J.0105-2896.2004.0135.X

1 reference

10 August 2017

1 reference